Higher heart attack risk from Vioxx reported

04/21/2004 | Forbes

One published study indicates people taking the arthritis drug Vioxx had a 24% higher risk of heart attack than those taking Celebrex, but only during the first 90 days of treatment. Vioxx manufacturer Merck & Co. said the study is not the final word on the subject and that other studies showed no different results from a placebo. The author agreed the data should not cause people to discontinue the medicine and said the elevation of risk only during the first three months may be because people susceptible to side effects are going to have them early.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA